Radiology plays an integral and fundamental role in managing breast cancer Published on 08/02/2024 Artificial intelligence (AI) contributes to improved diagnosis, faster image analysis and early detection.
The DIPCAN study seeks to change the way metastatic cancer is treated in Spain thanks to the integration of clinical, genomic, anatomic pathology and radiology image data from 2,000 patients Published on 22/02/2022 Participating patients will have free access to the genomic study of their tumor, both in the biopsy sample and in blood, to a full-body MRI and to digitization of anatomic pathology images
Artificial intelligence, liquid and genomic biopsy to personalize the treatment of endometrial cancer and improve the prognosis Published on 03/02/2022 MD Anderson Cancer Center Foundation Spain is participating in a project, with three other European countries, that will study tumors at a molecular level and seek to expand therapy options in the most advanced stages of endometrial cancer. The study will combine pre-clinical models and artificial intelligence solutions to generate an algorithm to predict the therapeutic response of patients. Endometrial cancer is the most common gynecological tumor in developed countries and the overall survival rate of patients is reduced from 90% to 17% if there is a late diagnosis1